FOXO genes are rearranged in various cancers [16,17]; FOXA1 is mutated in prostate and breast tumors [18,19,20,21], while FOXM1 has been shown to be a potent outcome predictor in various cancer types [22]. This evidence concerns the gene FOXA1 and cancer.